首页> 外文期刊>International Journal of Women s Health >Insertion of intrauterine devices after cesarean section: a systematic review update
【24h】

Insertion of intrauterine devices after cesarean section: a systematic review update

机译:剖宫产后子宫内器械的插入:系统评价更新

获取原文
       

摘要

Background: Women who undergo a cesarean section (CS) are in a unique position to receive the intrauterine contraceptive device (IUD). They may also want to use the IUD as a long-acting reversible contraceptive method provided the IUD is safe and effective in the presence of a CS scar. Search strategy: We researched and reviewed the MEDLINE, POPLINE, Google Scholar, and ClinicalTrials.gov databases from January 1968 to June 2015. Selection criteria: Eligible studies reported event rates or practical problems relating to IUD usage in post-placental or interval insertion (>90 days) after CS. Studies with ≥20 subjects were included. Data collection and analysis: Analysis of eligible data collected from the search followed the PRISMA guidelines. Main results: Twelve eligible studies of post-placental IUD insertion after CS included four randomized controlled trials of post-placental versus delayed insertion. Women randomized to delayed insertion were less likely to receive a device. Six studies examined the problem of missing IUD threads at follow-up with only 30%–60% presence of strings observed. Conclusion: The IUD is a long-acting reversible contraceptive method that is suitable for use in all women undergoing CS. The problems of device expulsion, missing threads at follow-up, and the tendency of increased puerperal bleeding need to be solved. Solutions are proposed.
机译:背景:剖宫产(CS)的妇女处于独特的位置,可以接受宫内节育器(IUD)。他们还可能希望将宫内节育器用作长效可逆避孕方法,前提是该宫内节育器在存在CS疤痕的情况下是安全有效的。搜寻策略:1968年1月至2015年6月,我们研究并审查了MEDLINE,POPLINE,Google Scholar和ClinicalTrials.gov数据库。选择标准:合格的研究报告了与胎盘后或间隔插入IUD有关的事件发生率或实际问题( > 90天后)。包括对≥20个受试者的研究。数据收集和分析:对从搜索中收集的合格数据的分析遵循了PRISMA指南。主要结果:十二项合格的CS后胎盘后宫内节育器插入的合格研究包括四项胎盘后插入与延迟插入的随机对照试验。随机分配到延迟插入的妇女不太可能接受器械。六项研究在随访中检查了宫内节育器螺纹缺失的问题,仅观察到了30%至60%的琴弦。结论:宫内节育器是一种长效可逆避孕方法,适用于所有接受CS的妇女。需要解决装置退缩,随访时螺纹缺失以及产后出血增加的趋势等问题。提出了解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号